Board of Directors
President & CEO, Monterey Advisors
Art has twenty-five years of experience in the medical device industry as a CEO, a COO, a CFO, and other senior level operational and financial positions for both publicly held companies and private venture capital backed firms. Art has extensive operational and leadership experience in both large and small commercial stage companies and in pre-revenue clinical or development startup companies. Sector experiences include spine, electrophysiology, ophthalmology, hearing health care, and neurology. In addition to Providence, Art currently serve as a member of the Board of Directors for Relievant, Inc. and Transcend Medical, Inc.
CEO, Providence Medical Technology
Jeff is a healthcare entrepreneur with global experience in life sciences. He co-founded Providence Medical Technology in 2008 and has served as the company’s CEO and member of the Board of Directors since its inception. Jeff was responsible for raising each of the company’s financing rounds and led the initial product development, clinical, regulatory, and commercialization efforts. Jeff is focused on the company’s Purpose, “To build a passionate team that delivers innovative spinal technology to help patients enjoy pain free lives.”
Jeff also co-founded Pacific Surgical (Philippines distributorship), Thayer Intellectual Property (extremities medical device), Kolum Inc, (spinal implant), and GreenLight Medical (hospital procurement software).
Prior to Providence, Jeff held leadership positions in sales and operations at Medtronic, Kyphon, DePuy Spine, Cardinal Health, and AstraZeneca.
Jeff is a graduate of Brown University where he earned an AB in Organizational & Behavior Management.
Founder, MVM Life Science Partners
Steve founded MVM in 1997. Prior to setting up MVM, he was responsible for early-stage healthcare investments at Saunders, Karp & Megrue in New York City. Between 1988 and 1993 Steve was an Investigator of the Howard Hughes Medical Institute at the Boyer Center for Molecular Medicine at Yale, where he was also an Associate Professor of Medicine and Genetics. He has published more than 50 papers on the molecular genetics of human disease.
Steve has been involved in starting several US biotechnology companies and was acting CEO at UpToDate In Medicine in Wellesley, Mass. He practiced medicine at the John Radcliffe Hospital, Churchill Hospital, Guys Hospital, St Thomas’s Hospital, Hammersmith Hospital and the Institute of Neurology, Queen Square before taking up research into molecular genetics at Oxford University. He has a degree in Natural Sciences from Cambridge and a Doctorate in medicine from Oxford and is a member of the Royal College of Physicians of England.
Steve is also a member of the boards of Ambio, Inc., Cheetah Medical, Inc., Providence Medical Technology, Inc., Pulmagen Therapeutics Ltd and Zipline Medical, Inc. He was previously a director of Beacon Endoscopic Ltd, BioVex Group, Inc., Cara Therapeutics, Inc., Clavis Pharma ASA, Domantis Ltd, Gendaq Ltd, Momenta Pharmaceuticals, Inc., New Chemical Entities, Inc., Nova Science Ltd, Sangamo Biosciences, Inc., UpToDate, Inc., Xention Ltd and Vascular Pathways, Inc.
Principal, Stanmore Medical Investments
David is a member of the investment committee and works with SMI portfolio companies to determine strategic goals, implement marketing strategy and manage human resources.
David founded Stanmore Development, a leading regional real estate development firm specializing in healthcare assets in 2006 where he currently serves as President. Under David’s leadership, Stanmore Development delivered approximately 250,000 square feet of medical office buildings throughout the southeast. Prior to founding the Stanmore Companies, David worked as a financial analyst at CIBC World Markets’ Investment Banking Division.
David graduated from Colgate University where he played lacrosse. He received an MBA from the Darden School at the University of Virginia in 2006. He currently resides in Jupiter, Florida.
Venture Partner, Aphelion Capital
Robert W. Thomas has over 20 years of successful operational experience in the life sciences industry. Robert currently serves as a member of the Board of Directors for several healthcare companies, as well as serving on the Board for several non-profit organizations. Prior to his Board work, Robert served as the CEO of Fox Hollow Technologies and led the company from 12 employees in start-up mode through a successful public offering with over $200M in annualized revenue and a $1B market capitalization. Prior to FoxHollow, Robert served as Vice-President of Operations for Conceptus, and before that was a founder of TMP, Inc, a privately financed medical device start-up company. TMP was acquired in September 1992, by a current division of GE Healthcare, and Robert stayed on as Vice President for the TMP division through February 1998. Prior to TMP, Robert was a founder of Access Devices (acquired by Baxter Healthcare). Robert received a B.A. in Economics from Ursinus College.
Managing Partner, Revelation Partners
Dr. Scott is a founder and managing partner at Revelation Partners. He is also a managing partner at Leerink Revelation Healthcare Funds I & II and a partner in SC Everest and SC Granite – all of which are funds dedicated to secondary investing in healthcare. Collectively, those funds represent over $640 million in capital under management.
Prior to cofounding Leerink Revelation Partners, Dr. Scott was a director at Saints Capital for six years, where he focused on secondary opportunities across healthcare sectors including medical devices, diagnostics, healthcare services and biopharmaceuticals. Before joining Saints Capital in 2008, Dr. Scott worked at Burrill & Company, where he made healthcare investments for nearly four years. Prior to Burrill & Company, Dr. Scott was a general surgery resident at Oregon Health Science University in Portland, Oregon.
Dr. Scott has been an investor in many successful health care investments including Coherex Medical (acquired by JNJ), Enata Pharmaceuticals (public), Radius Health (public), iRhythm (public), Concentric Medical (acquired by Stryker), Pulsar Vascular (acquired by JNJ), Torax Medical (acquired by JNJ), Spiration (acquired by Olympus), and Evalve (acquired by Abbott Medical).